Cargando…

Prevalence and Predictors of Vascular Cognitive Impairment in Patients With CADASIL

BACKGROUND AND OBJECTIVES: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common monogenic form of stroke and early-onset dementia. We determined the prevalence of vascular cognitive impairment (VCI) in a group of patients with CADASI...

Descripción completa

Detalles Bibliográficos
Autores principales: Jolly, Amy A., Nannoni, Stefania, Edwards, Hayley, Morris, Robin G., Markus, Hugh S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421594/
https://www.ncbi.nlm.nih.gov/pubmed/35606149
http://dx.doi.org/10.1212/WNL.0000000000200607
_version_ 1784777629525606400
author Jolly, Amy A.
Nannoni, Stefania
Edwards, Hayley
Morris, Robin G.
Markus, Hugh S.
author_facet Jolly, Amy A.
Nannoni, Stefania
Edwards, Hayley
Morris, Robin G.
Markus, Hugh S.
author_sort Jolly, Amy A.
collection PubMed
description BACKGROUND AND OBJECTIVES: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common monogenic form of stroke and early-onset dementia. We determined the prevalence of vascular cognitive impairment (VCI) in a group of patients with CADASIL and investigated which factors were associated with VCI risk, including clinical, genetic, and MRI parameters. METHODS: Cognition was assessed in patients with genetically confirmed CADASIL (n = 176) and healthy controls (n = 265) (mean [SD] age 50.95 [11.35] vs 52.37 [7.93] years) using the Brief Memory and Executive Test (BMET) and the Montreal Cognitive Assessment (MoCA). VCI was defined according to previously validated cutoffs. We determined the prevalence of VCI and its associations with clinical risk factors, mutation location (epidermal growth factor–like repeats [EGFr] 1–6 vs EGFr 7–34), and MRI markers of small vessel disease. RESULTS: VCI was more common in patients with CADASIL than in controls; 39.8 vs 10.2% on the BMET and 47.7% vs 19.6% on the MOCA. Patients with CADASIL had worse performance across all cognitive domains. A history of stroke was associated with VCI on the BMET (OR 2.12, 95% CI [1.05, 4.27] p = 0.04) and MoCA (OR 2.55 [1.21, 5.41] p = 0.01), after controlling for age and sex. There was no association of VCI with mutation site. Lacune count was the only MRI parameter independently associated with VCI on the BMET (OR: 1.63, 95% CI [1.10, 2.41], p = 0.014), after controlling for other MRI parameters. These associations persisted after controlling for education in the sensitivity analyses. DISCUSSION: VCI is present in almost half of the patients with CADASIL with a mean age of 50 years. Stroke and lacune count on MRI were both independent predictors of VCI on the BMET.
format Online
Article
Text
id pubmed-9421594
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94215942022-08-30 Prevalence and Predictors of Vascular Cognitive Impairment in Patients With CADASIL Jolly, Amy A. Nannoni, Stefania Edwards, Hayley Morris, Robin G. Markus, Hugh S. Neurology Research Article BACKGROUND AND OBJECTIVES: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common monogenic form of stroke and early-onset dementia. We determined the prevalence of vascular cognitive impairment (VCI) in a group of patients with CADASIL and investigated which factors were associated with VCI risk, including clinical, genetic, and MRI parameters. METHODS: Cognition was assessed in patients with genetically confirmed CADASIL (n = 176) and healthy controls (n = 265) (mean [SD] age 50.95 [11.35] vs 52.37 [7.93] years) using the Brief Memory and Executive Test (BMET) and the Montreal Cognitive Assessment (MoCA). VCI was defined according to previously validated cutoffs. We determined the prevalence of VCI and its associations with clinical risk factors, mutation location (epidermal growth factor–like repeats [EGFr] 1–6 vs EGFr 7–34), and MRI markers of small vessel disease. RESULTS: VCI was more common in patients with CADASIL than in controls; 39.8 vs 10.2% on the BMET and 47.7% vs 19.6% on the MOCA. Patients with CADASIL had worse performance across all cognitive domains. A history of stroke was associated with VCI on the BMET (OR 2.12, 95% CI [1.05, 4.27] p = 0.04) and MoCA (OR 2.55 [1.21, 5.41] p = 0.01), after controlling for age and sex. There was no association of VCI with mutation site. Lacune count was the only MRI parameter independently associated with VCI on the BMET (OR: 1.63, 95% CI [1.10, 2.41], p = 0.014), after controlling for other MRI parameters. These associations persisted after controlling for education in the sensitivity analyses. DISCUSSION: VCI is present in almost half of the patients with CADASIL with a mean age of 50 years. Stroke and lacune count on MRI were both independent predictors of VCI on the BMET. Lippincott Williams & Wilkins 2022-08-02 /pmc/articles/PMC9421594/ /pubmed/35606149 http://dx.doi.org/10.1212/WNL.0000000000200607 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Jolly, Amy A.
Nannoni, Stefania
Edwards, Hayley
Morris, Robin G.
Markus, Hugh S.
Prevalence and Predictors of Vascular Cognitive Impairment in Patients With CADASIL
title Prevalence and Predictors of Vascular Cognitive Impairment in Patients With CADASIL
title_full Prevalence and Predictors of Vascular Cognitive Impairment in Patients With CADASIL
title_fullStr Prevalence and Predictors of Vascular Cognitive Impairment in Patients With CADASIL
title_full_unstemmed Prevalence and Predictors of Vascular Cognitive Impairment in Patients With CADASIL
title_short Prevalence and Predictors of Vascular Cognitive Impairment in Patients With CADASIL
title_sort prevalence and predictors of vascular cognitive impairment in patients with cadasil
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421594/
https://www.ncbi.nlm.nih.gov/pubmed/35606149
http://dx.doi.org/10.1212/WNL.0000000000200607
work_keys_str_mv AT jollyamya prevalenceandpredictorsofvascularcognitiveimpairmentinpatientswithcadasil
AT nannonistefania prevalenceandpredictorsofvascularcognitiveimpairmentinpatientswithcadasil
AT edwardshayley prevalenceandpredictorsofvascularcognitiveimpairmentinpatientswithcadasil
AT morrisrobing prevalenceandpredictorsofvascularcognitiveimpairmentinpatientswithcadasil
AT markushughs prevalenceandpredictorsofvascularcognitiveimpairmentinpatientswithcadasil